CLAY B. SIEGALL - 26 Mar 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
President and CEO, Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
26 Mar 2025
Net transactions value
+$999,459
Form type
4
Filing time
26 Mar 2025, 16:03:00 UTC
Previous filing
03 Feb 2025
Next filing
06 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $999,459 +137,100 +20% $7.29 806,736 26 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction report was $7.29, and the range of prices were between $7.16 and $7.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.